Chemoattractant receptor signaling and the control of lymphocyte migration

Immunologic Research

Volumn 34, Issue 3, 2006, Pages 211-227

  Kehrl, John H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Chemotaxis; Heterotrimeric G protein; Lymphocytes; Migration; Photosphoinositide 3 Kinases; RGS proteins

Indexed keywords

ACTIN RELATED PROTEIN 2; ACTIN RELATED PROTEIN 3; CHEMOATTRACTANT; CHEMOATTRACTANT RECEPTOR; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; DIACYLGLYCEROL; FOCAL ADHESION KINASE 2; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PROTEIN KINASE C LAMBDA; PROTEIN TYROSINE PHOSPHATASE SHP 1; RAC PROTEIN; RETINA S ANTIGEN; RGS PROTEIN; RHO KINASE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VAV PROTEIN; WISKOTT ALDRICH SYNDROME PROTEIN;

CELL FUNCTION; CHEMOTAXIS; COMPLEX FORMATION; ENZYME ACTIVITY; HUMAN; HYDROLYSIS; IMAGING SYSTEM; LEUKOCYTE MOTILITY; LYMPHOCYTE MIGRATION; NEUTROPHIL CHEMOTAXIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REACTION TIME; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL MOVEMENT; GTP-BINDING PROTEINS; HUMANS; LYMPHOCYTES; MODELS, MOLECULAR; RECEPTORS, FORMYL PEPTIDE; SIGNAL TRANSDUCTION;

EID: 33746911971     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:34:3:211     Document Type: Review

References (112)

1. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-314.
2. Kunkel EJ, Butcher EC: Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002;16:1-4.
3. Rot A, von Andrian UH: Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004;22:891-928.
4. Balabanian K, Lagane B, Pablos JL, et al: WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. Blood 2005;105:2449-2457.
5. Norman MU, Hickey MJ: Mechanisms of lymphocyte migration in autoimmune disease. Tissue Antigens 2005;66:163-172.
6. Proudfoot AE, Power CA, Wells TN: The strategy of blocking the chemokine system to combat disease. Immunol Rev 2000;177:246-256.
7. Power CA: Knock out models to dissect chemokine receptor function in vivo. J Immunol Methods 2003;273:73-82.
8. Wells TN, Power CA, Shaw JP, Proudfoot AE: Chemokine blockers - therapeutics in the making? Trends Pharmacol Sci 2006;27:41-47.
9. Marinissen MJ, Gutkind JS: G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 2001;22:368-376.
10. Onuffer JJ, Horuk R: Chemokines, chemokine receptors and small-molecule antagonists: recent developments. Trends Pharmacol Sci 2002;23:459-467.
11. Cyster JG: Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 2005;23:127-159.
12. Neer EJ: Heterotrimeric G proteins: organizers of transmembrane signals. Cell 1995;80:249-257.
13. Hamm HE, Gilchrist A: Heterotrimeric G proteins. Curr Opin Cell Biol 1996;8:189-196.
14. Offermanns S, Simon MI: Organization of transmembrane signalling by heterotrimeric G proteins. Cancer Surv 1996;27:177-198.
15. Luttrell LM, Daaka Y, Lefkowitz RJ: Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol 1999;11:177-183.
16. Ahr B, Denizot M, Robert-Hebmann V, Brelot A, Biard-Piechaczyk M: Identification of the cytoplasmic domains of CXCR4 involved in Jak2 and STAT3 phosphorylation. J Biol Chem 2005;280:6692-6700.
17. Moriguchi M, Hissong BD, Gadina M, et al: CXCL12 signaling is independent of Jak2 and Jak3. J Biol Chem 2005;280:17408-17414.
18. Koelle MR, Horvitz HR: EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins. Cell 1996;84:115-125.
19. Druey KM, Blumer KJ, Kang VH, Kehrl JH: Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature 1996;379:742-746.
20. Berman DM, Wilkie TM and Gilman AG: GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 1996;86:445-452.
21. Zhong H,Wade SM,Woolf PJ, Linderman JJ, Traynor JR, Neubig RR: A spatial focusing model for G protein signals. Regulator of G protein signaling (RGS) protein-mediated kinetic scaffolding. J Biol Chem 2003;278:7278-7284.
22. Benians A, Nobles M, Hosny S, Tinker A: Regulators of G-protein signaling form a quaternary complex with the agonist, receptor, and G-protein. A novel explanation for the acceleration of signaling activation kinetics. J Biol Chem 2005;280:13383-13394.
23. Lefkowitz RJ, Whalen EJ: beta-arrestins: traffic cops of cell signaling. Curr Opin Cell Biol 2004;16:162-168.
24. Bargatze RF, Butcher EC: Rapid G protein-regulated activation event involved in lymphocyte binding to high endothelial venules. J Exp Med 1993;178:367-372.
25. Cyster JG, Goodnow CC: Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords. J Exp Med 1995;182:581-586.
26. Spangrude GJ, Braaten BA, Daynes RA: Molecular mechanisms of lymphocyte extravasation. I. Studies of two selective inhibitors of lymphocyte recirculation. J Immunol 1984;132:354-362.
27. Kehrl JH: G-protein-coupled receptor signaling, RGS proteins, and lymphocyte function. Crit Rev Immunol 2004;24:409-423.
28. Arai H, Tsou CL, Charo IF: Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 2B: evidence that directed migration is mediated by betagamma dimers released by activation of Galphai-coupled receptors. Proc Natl Acad Sci USA 1997;94:14495-14499.
29. Neptune ER, Bourne HR: Receptors induce chemotaxis by releasing the betagamma subunit of Gi, not by activating Gq or Gs. Proc Natl Acad Sci USA 1997;94:14489-14494.
30. Rudolph U, Finegold MJ, Rich SS, et al: Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet 1995;10:143-150.
31. Han SB, Moratz C, Huang NN, et al: Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles. Immunity 2005;22:343-354.
32. Hwang JI, Fraser ID, Choi S, Qin XF, Simon MI: Analysis of C5a-mediated chemotaxis by lentiviral delivery of small interfering RNA. Proc Natl Acad Sci USA 2004;101:488-493.
33. Hwang JI, Choi S, Fraser ID, Chang MS, Simon MI: Silencing the expression of multiple Gbeta-subunits eliminates signaling mediated by all four families of G proteins. Proc Natl Acad Sci USA 2005;102:9493-9498.
34. Chen CK, Eversole-Cire P, Zhang H, et al: Instability of GGL domain-containing RGS proteins in mice lacking the G protein beta-subunit Gbeta5. Proc Natl Acad Sci USA 2003;100:6604-6609.
35. Offermanns S, Simon MI: Genetic analysis of mammalian G-protein signalling. Oncogene 1998;17:1375-1381.
36. Girkontaite I, Missy K, Sakk V, et al: Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat Immunol 2001;2:855-862.
37. Rubtsov A, Strauch P, Digiacomo A, Hu J, Pelanda R, Torres RM: Lsc regulates marginal-zone B cell migration and adhesion and is required for the IgM T-dependent antibody response. Immunity 2005;23:527-538.
38. Coffield VM, Helms WS, Jiang Q, Su L: Galpha13 mediates a signal that is essential for proliferation and survival of thymocyte progenitors. J Exp Med 2004;200:1315-1324.
39. Sierra DA, Gilbert DJ, Householder D, et al: Evolution of the regulators of G-protein signaling multigene family in mouse and human. Genomics 2002;79:177-185.
40. Kozasa T, Jiang X, Hart MJ, et al: p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science 1998;280:2109-2111.
41. Koelle MR: A new family of G-protein regulators - the RGS proteins. Curr Opin Cell Biol 1997;9:143-147.
42. Kehrl JH: Heterotrimeric G protein signaling: roles in immune function and fine-tuning by RGS proteins. Immunity 1998;8:1-10.
43. Ross EM, Wilkie TM: GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 2000;69:795-827.
44. Martin-McCaffrey L,Willard FS, Oliveira-dos-Santos AJ, et al: RGS14 is a mitotic spindle protein essential from the first division of the mammalian zygote. Dev Cell 2004;7:763-769.
45. Cho H, Kim DU, Kehrl JH: RGS14 is a centrosomal and nuclear cytoplasmic shuttling protein that traffics to promyelocytic leukemia nuclear bodies following heat shock. J Biol Chem 2005;280:805-814.
46. Chen CK, Burns ME, He W, Wensel TG, Baylor DA, Simon MI: Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1. Nature 2000;403:557-560.
47. Oliveira-Dos-Santos AJ,Matsumoto G, Snow BE, et al: Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci USA 2000;97:12272-12277.
48. Heximer SP,Watson N, Linder ME, Blumer KJ, Hepler JR: RGS2/G0S8 is a selective inhibitor of Gqalpha function. Proc Natl Acad Sci USA 1997;94:14389-14393.
49. Moratz C, Hayman JR, Gu H, Kehrl JH: Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1-/- mice. Mol Cell Biol 2004;24:5767-5775.
50. Johnson EN, Druey KM: Functional characterization of the G protein regulator RGS13. J Biol Chem 2002;277:16768-16774.
51. Shi GX, Harrison K,Wilson GL, Moratz C, Kehrl JH: RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13. J Immunol 2002;169:2507-2515.
52. Lippert E, Yowe DL, Gonzalo JA, et al: Role of regulator of G protein signaling 16 in inflammation-induced T lymphocyte migration and activation. J Immunol 2003;171:1542-1555.
53. Han J-I, Huang N-N, Kim DU, Kehrl JH: RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization. J. Leukocyte Biol 2006;79:1357-1368.
54. Ma YC, Huang J, Ali S, Lowry W, Huang XY: Src tyrosine kinase is a novel direct effector of G proteins. Cell 2000;102:635-646.
55. Hidi R, Timmermans S, Liu E, et al: Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis. Eur Respir J 2000;15:342-349.
56. Inngjerdingen M, Torgersen KM, Maghazachi AA: Lck is required for stromal cell-derived factor 1 alpha (CXCL12)-induced lymphoid cell chemotaxis. Blood 2002;99:4318-4325.
57. Okabe S, Fukuda S, Kim YJ, et al: Stromal cell-derived factor-1alpha/CXCL12-induced chemotaxis of T cells involves activation of the RasGAP-associated docking protein p62Dok-1. Blood 2005;105:474-480.
58. Jiang Y, Ma W,Wan Y, Kozasa T, Hattori S, Huang XY: The G protein G alpha12 stimulates Bruton's tyrosine kinase and a rasGAP through a conserved PH/BM domain. Nature 1998;395:808-813.
59. Shi CS, Sinnarajah S, Cho H, Kozasa T, Kehrl JH: G13alpha-mediated PYK2 activation. PYK2 is a mediator of G13alpha -induced serum response element-dependent transcription. J Biol Chem 2000;275:24470-24476.
60. Kurose H: Galpha12 and Galpha13 as key regulatory mediator in signal transduction. Life Sci 2003;74:155-161.
61. Francis SA, Shen X,Young JB, Kaul P, Lerner DJ: Rho GEF Lsc is required for normal polarization, migration, and adhesion of formyl-peptide-stimulated neutrophils. Blood 2006;107:1627-1635.
62. Li Z, Jiang H, Xie W, Zhang Z, Smrcka AV, Wu D: Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science 2000;287:1046-1049.
63. Jiang H, Kuang Y, Wu Y, Xie W, Simon MI, Wu D: Roles of phospholipase C beta2 in chemoattractant-elicited responses. Proc Natl Acad Sci USA 1997;94:7971-7975.
64. Lodowski DT, Barnhill JF, Pyskadlo RM, Ghirlando R, Sterne-Marr R, Tesmer JJ: The role of G beta gamma and domain interfaces in the activation of G protein-coupled receptor kinase 2. Biochemistry 2005;44:6958-6970.
65. Loudon RP, Perussia B, Benovic JL: Differentially regulated expression of the G-protein-coupled receptor kinases, betaARK and GRK6, during myelomonocytic cell development in vitro. Blood 1996;88:4547-4557.
66. Fong AM, Premont RT, Richardson RM, Yu YR, Lefkowitz RJ, Patel DD: Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc Natl Acad Sci USA 2002;99:7478-7483.
67. Shenoy SK, Lefkowitz RJ: Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J 2003;375:503-515.
68. Cant SH, Pitcher JA: G protein-coupled receptor kinase 2-mediated phosphorylation of ezrin is required for G protein-coupled receptor-dependent reorganization of the actin cytoskeleton. Mol Biol Cell 2005;16:3088-3099.
69. Lee JH, Katakai T, Hara T, Gonda H, Sugai M, Shimizu A: Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation. J Cell Biol 2004;167:327-337.
70. Jaber M, Koch WJ, Rockman H, et al: Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc Natl Acad Sci USA 1996;93:12974-12979.
71. Vroon A, Heijnen CJ, Lombardi MS, et al: Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4. J Leukoc Biol 2004;75:901-909.
72. Stephens LR, Eguinoa A, Erdjument-Bromage H, et al: The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell 1997;89:105-114.
73. Suire S, Coadwell J, Ferguson GJ, Davidson K, Hawkins P, Stephens L: p84, a new Gbetagamma-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110gamma. Curr Biol 2005;15:566-570.
74. Sasaki T, Irie-Sasaki J, Jones RG, et al: Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 2000;287:1040-1046.
75. Hirsch E, Katanaev VL, Garlanda C, et al: Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 2000;287:1049-1053.
76. Reif K, Okkenhaug K, Sasaki T, Penninger JM, Vanhaesebroeck B, Cyster JG: Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J Immunol 2004;173:2236-2240.
77. Ortolano S, Hwang I-Y, Han SB, Kehrl JH: Role for phosphoinositide 3-kinases, Bruton's tyrosine kinase, and Jun kinases in B-lymphocyte chemotaxis and homing. Eur J Immunol 2006; 36:1285-1295.
78. Manahan CL, Iglesias PA, Long Y, Devretoes PN: Chemoattractant signaling in Dictyostelium discoideum. Ann. Rev Cell Dev Biol 2004;20:223-253.
79. Wang F, Herzmark P,Weiner OD, Srinivasan S, Servant G, Bourne HR: Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils. Nat Cell Biol 2002;4:513-518.
80. Xu J,Wang F, Van Keymeulen A, et al: Divergent signals and cytoskeletal assemblies regulate self-organizing polarity in neutrophils. Cell 2003;114:201-214.
81. Devreotes P, Janetopoulos C: Eukaryotic chemotaxis: distinctions between directional sensing and polarization. J Biol Chem 2003;278:20445-20448.
82. Arrieumerlou C, Meyer T: A local coupling model and compass parameter for eukaryotic chemotaxis. Dev Cell 2005;8:215-227.
83. Manes S, Gomez-Mouton C, Lacalle RA, Jimenez-Baranda S, Mira E, Martinez AC: Mastering time and space: immune cell polarization and chemotaxis. Semin Immunol 2005;17:77-86.
84. Schoenwaelder SM, Burridge K: Bidirectional signaling between the cytoskeleton and integrins. Curr Opin Cell Biol 1999;11:274-286.
85. Kinashi T, Katagiri K: Regulation of immune cell adhesion and migration by regulator of adhesion and cell polarization enriched in lymphoid tissues. Immunology 2005;116:164-171.
86. Rossman KL, Der CJ, Sondek J: GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 2005;6:167-180.
87. Srinivasan S, Wang F, Glavas S, et al: Rac and Cdc42 play distinct roles in regulating PI(3,4,5)P3 and polarity during neutrophil chemotaxis. J Cell Biol 2003;160:375-385.
88. Croker BA, Tarlinton DM, Cluse LA, et al: The Rac2 guanosine triphosphatase regulates B lymphocyte antigen receptor responses and chemotaxis and is required for establishment of B-1a and marginal zone B lymphocytes. J Immunol 2002;168:3376-3386.
89. Fukui Y, Hashimoto O, Sanui T, et al: Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature 2001;412:826-831.
90. Cote JF, Motoyama AB, Bush JA,Vuori K: A novel and evolutionarily conserved PtdIns(3,4,5)P3-binding domain is necessary for DOCK180 signalling. Nat Cell Biol 2005;7:797-807.
91. Vicente-Manzanares M, Cruz-Adalia A, Martin-Cofreces NB, et al: Control of lymphocyte shape and the chemotactic response by the GTP exchange factor Vav. Blood 2005;105:3026-3034.
92. Takesono A, Horai R, Mandai M, Dombroski D, Schwartzberg PL: Requirement for Tec kinases in chemokine-induced migration and activation of Cdc42 and Rac. Curr Biol 2004;14:917-922.
93. Welch HC, Coadwell WJ, Ellson CD, et al: P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. Cell 2002;108:809-821.
94. Hill K, Krugmann S, Andrews SR, et al: Regulation of P-Rex1 by phosphatidylinositol (3,4,5)-trisphosphate and Gbetagamma subunits. J Biol Chem 2005;280:4166-4173.
95. Dong X, Mo Z, Bokoch G, Guo C, Li Z,Wu D: P-Rex1 is a primary Rac2 guanine nucleotide exchange factor in mouse neutrophils. Curr Biol 2005;15:1874-1879.
96. Haddad E, Zugaza JL, Louache F, et al: The interaction between Cdc42 and WASP is required for SDF-1-induced T-lymphocyte chemotaxis. Blood 2001;97:33-38.
97. Li Z, Hannigan M, Mo Z, et al: Directional sensing requires G beta gamma-mediated PAK1 and PIX alpha-dependent activation of Cdc42. Cell 2003;114:215-227.
98. Vicente-Manzanares M, Rey M, Perez-Martinez M, et al: The RhoA effector mDia is induced during T cell activation and regulates actin polymerization and cell migration in T lymphocytes. J Immunol 2003;171:1023-1034.
99. Giagulli C, Scarpini E, Ottoboni L, et al: RhoA and zeta PKC control distinct modalities of LFA-1 activation by chemokines: critical role of LFA-1 affinity triggering in lymphocyte in vivo homing. Immunity 2004;20:25-35.
100. Bardi G, Niggli V, Loetscher P: Rho kinase is required for CCR7-mediated polarization and chemotaxis of T lymphocytes. FEBS Lett 2003;542:79-83.
101. Shimonaka M, Katagiri K, Nakayama T, et al: Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow. J Cell Biol 2003;161:417-427.
102. Katagiri K, Maeda A, Shimonaka M, Kinashi T: RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat Immunol 2003;4:741-748.
103. Katagiri K, Ohnishi N, Kabashima K, et al: Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking. Nat Immunol 2004;5:1045-1051.
104. Cahalan MD, Parker I, Wei SH, Miller MJ: Two-photon tissue imaging: seeing the immune system in a fresh light. Nat Rev Immunol 2002;2:872-880.
105. Germain RN, Castellino F, Chieppa M, et al: An extended vision for dynamic high-resolution intravital immune imaging. Semin Immunol 2005;17:431-441.
106. Halin C, Rodrigo Mora J, Sumen C, von Andrian UH: In vivo imaging of lymphocyte trafficking. Annu Rev Cell Dev Biol 2005;21:581-603.
107. Yin X, Chtanova T, Ladi E, Robey EA: Thymocyte motility: mutants, movies and migration patterns. Curr Opin Immunol 2006;18:191-197.
108. von Andrian UH, M'Rini C: In situ analysis of lymphocyte migration to lymph nodes. Cell Adhes Commun 1998;6:85-96.
109. Laudanna C, Constantin G: New models of intravital microscopy for analysis of chemokine receptor-mediated leukocyte vascular recognition. J Immunol Methods 2003;273:115-123.
110. Grayson MH, Hotchkiss RS, Karl IE, Holtzman MJ, Chaplin DD: Intravital microscopy comparing T lymphocyte trafficking to the spleen and the mesenteric lymph node. Am J Physiol Heart Circ Physiol 2003;284:H2213-2226.
111. Wei SH, Parker I, Miller MJ, Cahalan MD: A stochastic view of lymphocyte motility and trafficking within the lymph node. Immunol Rev 2003;195:136-159.
112. Okada T, Miller MJ, Parker I, et al: Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells. Plos Biology 2005;3:1-15.